ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,789.70
0.52%
S&P ASX All Technology
3,450.00
0.25%
Brent Oil
70.285
0.00%
US Dollar vs AUD
1.57978
0.00%
Bitcoin
84,198.03
-0.18%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Celyad Oncology SA (CYAD) Share Price

Celyad Oncology SA

Celyad Oncology SA (CYAD)

EU
0.57
0.012
(2.15%)
Closed 16 March 3:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.57
Bid
0.55
Offer
0.57
Volume
35,201
0.535 Day's Range 0.572
0.212 52 Week Range 1.22
Market Cap
23.615M
Previous Close
0.558
Open
0.557
Last Trade
3854
@
0.57
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
72,182
Shares Outstanding
41,429,000
Dividend Yield
-
PE Ratio
-2.80
Earnings Per Share (EPS)
-0.2
Revenue
102k
Net Profit
-8.45M

About Celyad Oncology SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.celyad.com
Headquarters
Mont-saint-guibert, Walloon Brabant, Bel
Founded
-
Celyad Oncology SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker CYAD. The last closing price for Celyad Oncology was 0.56 €. Over the last year, Celyad Oncology shares have traded in a share price range of 0.212 € to 1.22 €.

Celyad Oncology currently has 41,429,000 shares in issue. The market capitalisation of Celyad Oncology is 23.12 € million. Celyad Oncology has a price to earnings ratio (PE ratio) of -2.80.

Ask ADVFN Intelligence (AI)

CYAD Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0918.750.480.6190.4505825050.53905421DE
40.145534.27561837460.42450.9640.411552870.62601162DE
12-0.131-18.68758915830.7010.9640.41721820.61258659DE
260.3421500.2281.220.228796210.66054095DE
520.21560.56338028170.3551.220.212463920.60018575DE
156-1.408-71.18301314461.9782.550.212411500.94646599DE
260-5.22-90.15544041455.7912.080.212425142.90981975DE

CYAD - Frequently Asked Questions (FAQ)

What is the current Celyad Oncology share price?
The current share price of Celyad Oncology is 0.57 €
How many Celyad Oncology shares are in issue?
Celyad Oncology has 41,429,000 shares in issue
What is the market cap of Celyad Oncology?
The market capitalisation of Celyad Oncology is EUR 23.12M
What is the 1 year trading range for Celyad Oncology share price?
Celyad Oncology has traded in the range of 0.212 € to 1.22 € during the past year
What is the PE ratio of Celyad Oncology?
The price to earnings ratio of Celyad Oncology is -2.8
What is the cash to sales ratio of Celyad Oncology?
The cash to sales ratio of Celyad Oncology is 228
What is the reporting currency for Celyad Oncology?
Celyad Oncology reports financial results in EUR
What is the latest annual turnover for Celyad Oncology?
The latest annual turnover of Celyad Oncology is EUR 102k
What is the latest annual profit for Celyad Oncology?
The latest annual profit of Celyad Oncology is EUR -8.45M
What is the registered address of Celyad Oncology?
The registered address for Celyad Oncology is AXIS BUSINESS PARK, RUE ANDRE DUMONT 9, MONT-SAINT-GUIBERT, WALLOON BRABANT, 1435
What is the Celyad Oncology website address?
The website address for Celyad Oncology is www.celyad.com
Which industry sector does Celyad Oncology operate in?
Celyad Oncology operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SGDDSSpineguard DS
0.0004 €
(300.00%)
1.34M
MLCOTCoretech 5
0.05 €
(96.08%)
2.15k
BNBSTonner Drones
0.003 €
(50.00%)
3.21M
LUDSLucibel DS
0.0007 €
(40.00%)
400.23k
ALVIOValerio Therapeutics
0.083 €
(39.50%)
2.29M
ALCYBCybergun
0.0002 €
(-33.33%)
294.97M
ABLDABL Diagnostics
5.60 €
(-22.76%)
4.5k
ALALOAcheterLouerFR
0.0033 €
(-21.43%)
44.77M
DMSBSDiagnostic Medical Systems
0.004 €
(-20.00%)
1.3k
ALEXPOne Experience
0.38 €
(-19.15%)
170
ATOAtos SE
0.004 €
(-4.76%)
494.38M
ALCYBCybergun
0.0002 €
(-33.33%)
294.97M
BCPBanco Comercial Portugues SA
0.5516 €
(4.00%)
88.1M
ALEUPEuroplasma
0.0202 €
(1.51%)
73.21M
ALTDTonner Drones
0.0234 €
(-14.60%)
60.14M

Discussion

View Full Feed
tradero tradero 3 minutes ago
I also find interesting this new change in YL’s speech from the last CC
First time he spoke, he pinpointed to the 2 short-term main goals he foresaw:
1. Getting design-wins with Perk inside
2. Convincing foundries to use Perk
LWLG
Horsts Horsts 7 minutes ago
Are not more than fan articles for dreamers 
SHIBUSD
Horsts Horsts 8 minutes ago
123456
CLRB
Horsts Horsts 12 minutes ago
So called Altcoinseason is over just before it really has begun.This time you have ETFs and a lot big player within the game.Time has changed.And everything except Bitcoin, Solana, XRP and ETH are not more than 
SHIBUSD
Ikeboogie Ikeboogie 21 minutes ago
YOU ARE HENRY RICE BRAIN
PHIL
SteveSchiets SteveSchiets 23 minutes ago
I'm sure i i'm able to vote. Saxo, my broker hasn't send me anything.

The vote was on 14th?
SEV
Investor2014 Investor2014 30 minutes ago
Yes that’s all true. Patent law is complex and intricate - well beyond a message board lecture.
AVXL
pgsd pgsd 31 minutes ago
Pfizer reported that their vepdegestrant program did not extend progression-free survival rates in the overall population of a Phase 3 breast cancer study.

This is interesting as one of the Phase 2 clinical trials $nwbo has in-licensed from Roswell Park is for the same indication...
ARVN NWBO
Seminole Red Seminole Red 48 minutes ago
https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/483894718_1085575200276736_2768001607314243190_n.jpg?_nc_cat=100&ccb=1-7&_nc_sid=127cfc&_nc_ohc=yk7g-ZyBwFAQ7kNvgFptRV2&_nc_oc=Adic5JaF647YA-umYK7jDgu27_y7b47tvJ7fhpbqkPwvwLYL1_B4fKWcdpidxiF8m1yU-EHxzB6YyTqd4dec5lJq&_nc_zt=23&_nc_ht=scontent-mia3-1.
jeunke22 jeunke22 54 minutes ago
Sure, it’s a cumulative effort which results in new energy , reinforcement and a possible snow ball effect . Hope you get the idea.
LWLG
TightCoil TightCoil 56 minutes ago
Because they spelled S-C-A-R-L-E-T ?
FNMA
Chiugray Chiugray 57 minutes ago
VMLG17, Well said.

All I can say is this. My personal investment thesis:
- NWBO is a unicorn company and investment
- NWBO's price is manipulated to extremely low levels now

Within weeks of post-approval, NWBO will make a first stop at $5/sh, a 20X increa
NWBO
shazam1355 shazam1355 1 hour ago
Jeunke could you elaborate a little more for us simpletons what you mean by "momentum building" ? What in particular are you referring to from the Yves update last Thursday call?
LWLG
adagium adagium 1 hour ago
Enabling 400G per Lane Transceivers
The spike in transceiver demand for AI cluster and data center application is a consequence of the increased data traffic coming from the introduction of large language models (LLM) that power the life of ever more humans every day. Not only the numbers of
LWLG
jeunke22 jeunke22 1 hour ago
I expect ‘momentum building ‘ announcements around OFC which is 1/3 April. Yves told us that’s the time for the company to get maximum exposure. The pressure is on to make it happen, so much is clear to me from the latest company presentation. Fingers crossed.
LWLG
RickNagra RickNagra 1 hour ago
Oh wow.  I am a genius.  I am a legend.  Please allow me to explain.  I have a lot of experience with this type of stuff and it seems to me that the most important aspect is the quality of the products.  DBMM has produced products and services that are very affordable and ve
DBMM
knrorrel knrorrel 2 hours ago
In any case, $QNCCF is interesting, from Monday and the chart looks like a breakout and everyone is waiting for the results with IBM and apparently there are many buyers, as you can see on Friday and probably just the beginning of a big recovery, maybe back to almost two dollars
all only imho
QNCCF
knrorrel knrorrel 2 hours ago
In any case, $QNCCF is interesting, from Monday and the chart looks like a breakout and everyone is waiting for the results with IBM and apparently there are many buyers, as you can see on Friday and probably just the beginning of a big recovery, maybe back to almost two dollars
all only imho
QNCCF
facts_matter14 facts_matter14 2 hours ago
The special number is $0.00 cash on hand.







.
SRMX
facts_matter14 facts_matter14 2 hours ago
The special number is -99% since 2-12-21.







.
SRMX
facts_matter14 facts_matter14 2 hours ago
The special number is now .0001










.
SRMX

Your Recent History

EU
CYAD
Celyad Oncology
EU
SFPI
Groupe SFPI
TSX
HGU
BetaPro Canadian Gold Mi...
NYSE
MY
DOWI
DJTNCG
DJ Personal and Househol...
LSE
XUTC
Xm Usa It
NASDAQ
CHXJX
International Equity Val...
DOWI
DJTATOT
DJ Automobiles and Parts...
ASX
XCLWAV
Australian Commonwealth
BIT
UC5CFE
Unicredit Bank
BIT
UV8CW7
UniCredit Bank
BIT
UC5GT3
Unicredit Bank
BIT
UC5645
Unicredit Bank
BIT
UC65MM
Unicredit Bank
USOTC
IDGC
ID Global (CE)
BIT
UB8LJP
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads